Siobhan Sutcliffe1, Charles Cain2,3, Tamara Bavendam4, Colleen M Fitzgerald5, Sheila Gahagan6, Alayne D Markland7, David A Shoham8, Ariana L Smith9, Kyle Rudser2. 1. Division of Public Health Sciences, Department of Surgery; Department of Obstetrics and Gynecology; and the Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri. 2. Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, Minnesota. 3. Medtronic, Minneapolis, Minnesota. 4. National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland. 5. Division of Female Pelvic Medicine and Reconstructive Surgery, Department of Obstetrics and Gynecology, Stritch School of Medicine, Loyola University Chicago, Maywood, Illinois. 6. Division of Child Development and Community Health, University of California, San Diego, California. 7. Division of Gerontology, Geriatrics, and Palliative Care, Department of Medicine at the University of Alabama at Birmingham and the Birmingham Geriatric Research, Education, and Clinical Center at the Birmingham VAMC, Birmingham, Alabama. 8. Department of Biostatistics and Epidemiology, College of Public Health, East Tennessee State University, Johnson City, Tennessee. 9. Division of Urology, Department of Surgery, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
Abstract
PURPOSE: Our goal was to describe changes in bladder health, defined as "a complete state of physical, mental, and social well-being related to bladder function that permits daily activities, adapts to short-term stressors, and allows optimal well-being," in women over time. MATERIALS AND METHODS: We used data on 15 lower urinary tract symptoms (LUTS) and interference from urinary experiences assessed at the baseline and 5-year followup interviews of the BACH (Boston Area Community Health) Survey to estimate changes in bladder health over time in women. Associations between baseline and followup bladder health (defined as the maximum frequency of LUTS or interference at each time point) were calculated by ordinal logistic regression and generalized linear models. RESULTS: A total of 2,526 women provided complete information on bladder health at baseline and followup. Over the 5-year followup, 6.5% of women maintained optimal bladder health (no LUTS or interference), 33.6% developed worse bladder health (including 10.4% who transitioned from optimal to less than optimal health), 31.4% maintained their less than optimal bladder health status and 28.7% improved. Despite these changes, women with poorer bladder health at baseline were still more likely to have poorer bladder health 5 years later (eg multivariable-adjusted relative risk=3.27, 95% confidence interval: 2.49-4.29 for severe LUTS/interference at followup among those with severe LUTS/interference at baseline). CONCLUSIONS: Findings from our large secondary analysis of BACH Survey data suggest considerable variability in bladder health over time, and underscore the importance of bladder health promotion to prevent the initial onset and progression of poor bladder health in women.
PURPOSE: Our goal was to describe changes in bladder health, defined as "a complete state of physical, mental, and social well-being related to bladder function that permits daily activities, adapts to short-term stressors, and allows optimal well-being," in women over time. MATERIALS AND METHODS: We used data on 15 lower urinary tract symptoms (LUTS) and interference from urinary experiences assessed at the baseline and 5-year followup interviews of the BACH (Boston Area Community Health) Survey to estimate changes in bladder health over time in women. Associations between baseline and followup bladder health (defined as the maximum frequency of LUTS or interference at each time point) were calculated by ordinal logistic regression and generalized linear models. RESULTS: A total of 2,526 women provided complete information on bladder health at baseline and followup. Over the 5-year followup, 6.5% of women maintained optimal bladder health (no LUTS or interference), 33.6% developed worse bladder health (including 10.4% who transitioned from optimal to less than optimal health), 31.4% maintained their less than optimal bladder health status and 28.7% improved. Despite these changes, women with poorer bladder health at baseline were still more likely to have poorer bladder health 5 years later (eg multivariable-adjusted relative risk=3.27, 95% confidence interval: 2.49-4.29 for severe LUTS/interference at followup among those with severe LUTS/interference at baseline). CONCLUSIONS: Findings from our large secondary analysis of BACH Survey data suggest considerable variability in bladder health over time, and underscore the importance of bladder health promotion to prevent the initial onset and progression of poor bladder health in women.
Authors: David H Thom; Jeanette S Brown; Michael Schembri; Arona I Ragins; Leslee L Subak; Stephen K Van Den Eeden Journal: J Urol Date: 2010-08-19 Impact factor: 7.450
Authors: Kaitlin A Hagan; Elisabeth Erekson; Andrea Austin; Vatche A Minassian; Mary K Townsend; Julie P W Bynum; Francine Grodstein Journal: Am J Obstet Gynecol Date: 2018-02-06 Impact factor: 8.661
Authors: Jerry L Lowder; Tamara G Bavendam; Amanda Berry; Sonya S Brady; Colleen M Fitzgerald; Cynthia S Fok; Patricia S Goode; Cora E Lewis; Elizabeth R Mueller; Diane K Newman; Mary H Palmer; Leslie Rickey; Ann Stapleton; Emily S Lukacz Journal: Neurourol Urodyn Date: 2019-04-08 Impact factor: 2.696
Authors: Patricia S Goode; Kathryn L Burgio; David T Redden; Alayne Markland; Holly E Richter; Patricia Sawyer; Richard M Allman Journal: J Urol Date: 2008-03-04 Impact factor: 7.450
Authors: Susan A Hall; Amy Cinar; Carol L Link; Zoe S Kopp; Claus G Roehrborn; Steven A Kaplan; Raymond C Rosen Journal: BJU Int Date: 2008-05 Impact factor: 5.588
Authors: Philip B Gorelick; Karen L Furie; Costantino Iadecola; Eric E Smith; Salina P Waddy; Donald M Lloyd-Jones; Hee-Joon Bae; Mary Ann Bauman; Martin Dichgans; Pamela W Duncan; Meighan Girgus; Virginia J Howard; Ronald M Lazar; Sudha Seshadri; Fernando D Testai; Stephen van Gaal; Kristine Yaffe; Hank Wasiak; Charlotte Zerna Journal: Stroke Date: 2017-09-07 Impact factor: 7.914
Authors: Yuko M Komesu; Ronald M Schrader; Loren H Ketai; Rebecca G Rogers; Gena C Dunivan Journal: Int Urogynecol J Date: 2015-12-15 Impact factor: 2.894
Authors: Vitaly A Postoev; Andrej M Grjibovski; Anton A Kovalenko; Erik Eik Anda; Evert Nieboer; Jon Øyvind Odland Journal: Birth Defects Res A Clin Mol Teratol Date: 2016-02-02
Authors: Jori S Pesonen; Rufus Cartwright; Altaf Mangera; Henrikki Santti; Tomas L Griebling; Alexey E Pryalukhin; Jarno Riikonen; Riikka M Tähtinen; Arnav Agarwal; Johnson F Tsui; Camille P Vaughan; Alayne D Markland; Theodore M Johnson; Riikka Fonsell-Annala; Charlie Khoo; Teuvo L J Tammela; Yoshitaka Aoki; Anssi Auvinen; Diane Heels-Ansdell; Gordon H Guyatt; Kari A O Tikkinen Journal: Eur Urol Date: 2016-02-20 Impact factor: 20.096